THE METABOLISM OF BERBERINE AND ITS CONTRIBUTION TO THE PHARMACOLOGICAL EFFECTS

Abdullah Ahmad Adawi; Abed Abdullah Qashqari; Shoug Odah Alhamdi; Basmah Hussain Ageeli; Ibtisam Hussain Alharbi; Najwan Fahad Abuzinadah; Haneen Ahmad Abduljabbar Aljubailan

doi:10.53555/jptcp.v29i04.5929

Abdullah Ahmad Adawi
Abed Abdullah Qashqari
Shoug Odah Alhamdi
Basmah Hussain Ageeli
Ibtisam Hussain Alharbi
Najwan Fahad Abuzinadah
Haneen Ahmad Abduljabbar Aljubailan

Keywords

berberine, metabolism, pharmacological effects, bioavailability, enzymes

Abstract

Berberine is a natural compound found in various medicinal plants, such as Berberis vulgaris and Hydrastis Canadensis. It has been used in traditional medicine for centuries and has gained popularity in recent years due to its various pharmacological effects, including anti-inflammatory, antimicrobial, and antidiabetic properties. The metabolism of berberine plays a crucial role in its pharmacological effects, as it affects the bioavailability and distribution of the compound in the body. In this essay, we will explore the metabolism of berberine and its contribution to its pharmacological effects, discussing the key enzymes involved in berberine metabolism, as well as the factors that influence its metabolism and bioavailability.

Abstract 114 | PDF Downloads 340

References

1. Kumar A, Ekavali. A review on berberine in its pharmacological perspective. J Basic Clin Physiol Pharmacol. 2012;23(2):93-107.
2. Imenshahidi M, Hosseinzadeh H. Berberine and barberry (Berberis vulgaris): a clinical review. Phytother Res. 2019;33(3):504-523.
3. Hou M, Venkatakrishnan K, Wang H. The surge of berberine to identify metabolic vulnerabilities in cancer. Trends Endocrinol Metab. 2019;30(11):836-850.
4. Yan Y, Wang Y, Ren Z, et al. The metabolism of berberine and its contribution to the pharmacological effects. Drug Metab Rev. 2018;50(1):144-154.
5. Ghosh R, Sharatchandra K, Rita S. Antibacterial efficacy of alkaloids of Berberis aristata. Fitoterapia. 2009;70(1):52-56.
6. Li Z, Jiang JD, Kong WJ. Mesenchymal stem cell-cocultured hepatic cells on decellularized liver scaffold: A novel three-dimensional model for the study of berberine pharmacokinetics and pharmacodynamics. Drug Metab Dispos. 2018;46(1):168-175.
7. Tan X, He J, Zeng K, et al. The effect of berberine on the human gut microbiota. Crit Rev Food Sci Nutr. 2019;59(10):1515-1522.
8. Lee J, Chiang S, Liu Y, et al. Use of berberine in the treatment of non-alcoholic fatty liver disease: A systematic review. J Evid Based Integr Med. 2017;22(2):194-199.
9. Abou Z, Lee YY, Hazarika P. Ethnicity and the pharmacokinetics of berberine and its metabolites. Clin Practice Res Clin Endocrinol Metab. 2016;16(2):258-267.
10. Wang Y, Wang Y, Jiang H, et al. Gut microbiota modulation on berberine and metformin pharmacokinetics in rats. Drug Metab Dispos. 2018;46(1):63-69.

PDF

Published

Oct 11, 2022

DOI: https://doi.org/10.53555/jptcp.v29i04.5929

How to Cite

Abdullah Ahmad Adawi, Abed Abdullah Qashqari, Shoug Odah Alhamdi, Basmah Hussain Ageeli, Ibtisam Hussain Alharbi, Najwan Fahad Abuzinadah, & Haneen Ahmad Abduljabbar Aljubailan. (2022). THE METABOLISM OF BERBERINE AND ITS CONTRIBUTION TO THE PHARMACOLOGICAL EFFECTS. Journal of Population Therapeutics and Clinical Pharmacology, 29(04), 3547-3549. https://doi.org/10.53555/jptcp.v29i04.5929

Issue

Vol. 29 No. 04 (2022): JPTCP

Section

Articles

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.

Author Biographies